67Cu SAR bisRGD
Alternative Names: [67]Cu-SAR-bisRGD; [67Cu]Cu-SAR-bisRGDLatest Information Update: 26 Jul 2024
At a glance
- Originator Clarity Pharmaceuticals
- Class Antineoplastics; Peptides; Radioisotopes; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer